The condition primarily affects the peripheral nerves, which are responsible for transmitting signals between the brain, spinal cord, and muscles. It also impacts the nerves that control the laryngeal muscles, which regulate the opening and closing of the airway during breathing, eating, and vocalization. In dogs affected by JLPP, a genetic mutation disrupts normal nerve development and function, leading to progressive nerve degeneration.
Clinical signs of JLPP usually appear at a very young age, often within the first few months of life. One of the earliest and most recognizable symptoms is noisy breathing (stridor), especially during exercise, excitement, or stress. This occurs because the laryngeal muscles become weak or paralyzed, preventing proper opening of the airway. Puppies may also show a change in bark, coughing while eating or drinking, or difficulty swallowing.
As the disease progresses, respiratory difficulties can become more severe. Affected dogs may struggle with exercise intolerance, rapid fatigue, and episodes of breathing distress, especially in warm environments or during excitement. In advanced cases, airway obstruction can become life-threatening if not managed promptly.
In addition to respiratory signs, JLPP also causes progressive polyneuropathy, affecting limb coordination and muscle strength. Puppies may develop hind limb weakness, unsteady gait (ataxia), difficulty standing or walking, and reduced reflexes. Muscle wasting may occur over time due to reduced nerve stimulation. These neurological deficits worsen gradually as nerve degeneration continues.
The JLPP DNA Health Test is designed to detect the specific genetic mutation responsible for Juvenile Laryngeal Paralysis and Polyneuropathy. The test is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The DNA is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Because genetic information does not change throughout life, testing can be performed at any age, including in puppies before clinical signs develop.
Results are generally reported as:
- Clear (Normal): The dog does not carry the JLPP mutation and will not develop or pass on the disease.
- Carrier: The dog carries one copy of the mutation but typically does not show clinical signs. However, it can pass the mutation to offspring.
- Affected/At Risk: The dog carries two copies of the mutation and is expected to develop severe neurological and respiratory signs associated with JLPP.
Genetic testing for JLPP is extremely important for breeders, veterinarians, and dog owners. Breeders can use test results to eliminate carrier-to-carrier matings, helping prevent the birth of affected puppies and reducing the prevalence of this devastating disease in future generations.
For dog owners, early genetic knowledge allows for informed care decisions and monitoring. While there is currently no cure for JLPP, supportive management such as respiratory care, controlled activity, physiotherapy, and in some cases surgical intervention for airway support may help improve comfort and extend quality of life. Regular veterinary monitoring is essential due to the progressive nature of the disease.
The Juvenile Laryngeal Paralysis and Polyneuropathy (JLPP) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine neurological and respiratory health, and helps reduce the impact of this severe early-onset inherited disorder in future generations.
